Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 94.8 USD -5.39% Market Closed
Market Cap: 8.3B USD
Have any thoughts about
Healthequity Inc?
Write Note

Wall Street
Price Targets

HQY Price Targets Summary
Healthequity Inc

Wall Street analysts forecast HQY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HQY is 105.49 USD with a low forecast of 95.95 USD and a high forecast of 115.5 USD.

Lowest
Price Target
95.95 USD
1% Upside
Average
Price Target
105.49 USD
11% Upside
Highest
Price Target
115.5 USD
22% Upside

HQY Last Price Targets
Healthequity Inc

The latest public price target was made on Sep 4, 2024 by George Hill from Deutsche Bank , who expects HQY stock to rise by 9% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
George Hill
Deutsche Bank
103 USD
Upside 9%
2 months ago
Sep 4, 2024
HealthEquity, Inc (HQY) PT Raised to $103 at Deutsche Bank
StreetInsider
Stan Berenshteyn
Wells Fargo
110 USD
Upside 16%
4 months ago
Jun 20, 2024
HealthEquity price target raised to $110 from $107 at Wells Fargo
TheFly
Mark Marcon
Robert W. Baird
104 USD
Upside 10%
5 months ago
Jun 4, 2024
HealthEquity, Inc (HQY) PT Raised to $104 at Baird
StreetInsider
Scott Schoenhaus
KeyBanc
100 USD
Upside 5%
5 months ago
Jun 4, 2024
HealthEquity, Inc (HQY) PT Raised to $100 at KeyBanc
StreetInsider
Alexander Paris
Barrington
100 USD
Upside 5%
5 months ago
Jun 3, 2024
HealthEquity Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga
Stan Berenshteyn
Wells Fargo
105 USD
Upside 11%
6 months ago
May 7, 2024
HealthEquity, Inc (HQY) PT Raised to $105 at Wells Fargo
StreetInsider
Constantine Davides
JMP Securities
101 USD
Upside 7%
7 months ago
Apr 4, 2024
JMP Securities Starts HealthEquity, Inc (HQY) at Market Outperform, 'We expect HQY to continue its share gains'
StreetInsider
Glen Santangelo
Jefferies
95 USD
Upside 0%
7 months ago
Mar 28, 2024
HealthEquity, Inc (HQY) PT Raised to $95 at Jefferies, 'confident in biz trends and magnitude of tailwinds'
StreetInsider
Sean Dodge
RBC Capital
92 USD
Downside 3%
7 months ago
Mar 20, 2024
HealthEquity, Inc (HQY) PT Raised to $92 at RBC Capital
StreetInsider
Stephanie Davis
Barclays
104 USD
Upside 10%
7 months ago
Mar 20, 2024
Barclays Reiterates Overweight Rating on HealthEquity, Inc (HQY)
StreetInsider
Mark Marcon
Robert W. Baird
87 USD
Downside 8%
1 year ago
Sep 21, 2023
Baird Upgrades HealthEquity, Inc (HQY) to Outperform
StreetInsider
Scott Schoenhaus
Loop Capital Markets
85 USD
Downside 10%
1 year ago
Jun 6, 2023
HealthEquity To Capture More Market Share, Says Analyst In Overweight Rating Rationale
Benzinga
Show More Price Targets
Show Less Price Targets
George Hill
Deutsche Bank
Price Target 103 USD
Upside/Downside 9%
View Source
Stan Berenshteyn
Wells Fargo
Price Target 110 USD
Upside/Downside 16%
View Source
Mark Marcon
Robert W. Baird
Price Target 104 USD
Upside/Downside 10%
View Source
Scott Schoenhaus
KeyBanc
Price Target 100 USD
Upside/Downside 5%
View Source
Alexander Paris
Barrington
Price Target 100 USD
Upside/Downside 5%
View Source
Stan Berenshteyn
Wells Fargo
Price Target 105 USD
Upside/Downside 11%
View Source
Constantine Davides
JMP Securities
Price Target 101 USD
Upside/Downside 7%
View Source
Glen Santangelo
Jefferies
Price Target 95 USD
Upside/Downside 0%
View Source
Sean Dodge
RBC Capital
Price Target 92 USD
Upside/Downside 3%
View Source
Stephanie Davis
Barclays
Price Target 104 USD
Upside/Downside 10%
View Source
Mark Marcon
Robert W. Baird
Price Target 87 USD
Upside/Downside 8%
View Source
Scott Schoenhaus
Loop Capital Markets
Price Target 85 USD
Upside/Downside 10%
View Source
Show More Price Targets
Show Less Price Targets
Healthequity Inc Competitors:
Price Targets
CLOV
Clover Health Investments Corp
12% Downside
UNH
UnitedHealth Group Inc
5% Upside
MOH
Molina Healthcare Inc
23% Upside
HAPV3
Hapvida Participacoes e Investimentos SA
105% Upside
HUM
Humana Inc
4% Upside
ODPV3
Odontoprev SA
19% Upside
0HG8
Anthem Inc
37% Upside

Revenue
Forecast

Revenue Estimate
Healthequity Inc

For the last 8 years the compound annual growth rate for Healthequity Inc's revenue is 29%. The projected CAGR for the next 3 years is 14%.

29%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Healthequity Inc

For the last 8 years the compound annual growth rate for Healthequity Inc's operating income is 22%. The projected CAGR for the next 3 years is 40%.

22%
Past Growth
40%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Healthequity Inc

For the last 8 years the compound annual growth rate for Healthequity Inc's net income is 16%. The projected CAGR for the next 3 years is 91%.

16%
Past Growth
91%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HQY's stock price target?
Price Target
105.49 USD

According to Wall Street analysts, the average 1-year price target for HQY is 105.49 USD with a low forecast of 95.95 USD and a high forecast of 115.5 USD.

What is Healthequity Inc's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Healthequity Inc's revenue is 29%. The projected CAGR for the next 3 years is 14%.

What is Healthequity Inc's Operating Income forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for Healthequity Inc's operating income is 22%. The projected CAGR for the next 3 years is 40%.

What is Healthequity Inc's Net Income forecast?
Projected CAGR
91%

For the last 8 years the compound annual growth rate for Healthequity Inc's net income is 16%. The projected CAGR for the next 3 years is 91%.

Back to Top